Clinical Trial Update: Indocyanine Green for Perfusion Assessment of DIEP Flaps [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating indocyanine green for perfusion assessment of DIEP flaps in fat necrosis is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fat Necrosis

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Fat Necrosis | Phase 3 | Status: UNKNOWN